Related Experiment Video

Updated: Jun 20, 2026

Long-term Continuous EEG Monitoring in Small Rodent Models of Human Disease Using the Epoch Wireless Transmitter System
08:43

Long-term Continuous EEG Monitoring in Small Rodent Models of Human Disease Using the Epoch Wireless Transmitter System

Published on: July 21, 2015

Modified Atkins diet for the treatment of nonconvulsive status epilepticus in children

Tomohiro Kumada1, Tomoko Miyajima, Nobusuke Kimura

  • 1Department of Pediatrics, Shiga Medical Center for Children, Shiga, Japan. tkumada@mccs.jp

Journal of Child Neurology
|September 26, 2009
PubMed

Insights

The modified Atkins diet effectively treated nonconvulsive status epilepticus in two pediatric patients. This ketogenic therapy offers a promising alternative for children with drug-resistant epilepsy.

Area of Science:

  • Neurology
  • Pediatric Neurology
  • Nutritional Ketogenics

Background:

  • Nonconvulsive status epilepticus (NCSE) is a prolonged seizure state often resistant to standard antiepileptic drugs.
  • Pediatric epilepsy presents unique challenges, necessitating exploration of alternative therapeutic strategies.
  • The modified Atkins diet (MAD) is a ketogenic therapy with potential anticonvulsant properties.

Observation:

  • Two pediatric patients with refractory NCSE were treated with the modified Atkins diet.
  • Carbohydrate intake was restricted to 10 g/day, with no limits on protein, calories, or fluids.
  • Both patients experienced resolution of daily NCSE within 5 to 10 days of initiating the diet.

Findings:

  • The modified Atkins diet demonstrated significant efficacy in resolving NCSE in both pediatric cases.
  • Sustained seizure freedom was observed for 19 months in one patient and 4 months in the other.
  • This suggests the MAD can be a highly effective treatment for pediatric NCSE.

Implications:

  • The modified Atkins diet represents a viable and effective therapeutic option for pediatric nonconvulsive status epilepticus.
  • This dietary intervention may offer a valuable alternative for patients unresponsive to conventional antiepileptic medications.
  • Further research into ketogenic therapies for refractory epilepsy in children is warranted.

More Related Videos

Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy10:22

Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy

Published on: December 6, 2016

Electromagnetic Source Imaging in Presurgical Evaluation of Children with Drug-Resistant Epilepsy09:57

Electromagnetic Source Imaging in Presurgical Evaluation of Children with Drug-Resistant Epilepsy

Published on: September 20, 2024

Related Concept Videos

Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Depolarizing Blockers: Pharmocokinetics01:19

Depolarizing Blockers: Pharmocokinetics

Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
Antiepileptic Drugs: Calcium Channel Blockers01:17

Antiepileptic Drugs: Calcium Channel Blockers

Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...